Why the study?
Idiopathic ventricular fibrillation accounts for 5-7% of sudden cardiac arrests without identifiable structural disease or primary arrhythmic syndromes, yet the clinical characteristics, management, and prognosis of these patients remain unclear.
Does a catheter ablation strategy compared to medical management with antiarrhythmic drugs alone affect the recurrence of ventricular fibrillation in patients with true idiopathic ventricular fibrillation?
Cohort (n=132)
Yes
Does a catheter ablation strategy compared to medical management with antiarrhythmic drugs alone affect the recurrence of ventricular fibrillation in patients with true idiopathic ventricular fibrillation?
Answers are grounded in this paper and cite their sources.
Over a 9-year follow-up of initially diagnosed IVF patients, over a quarter were later found to have structural or primary arrhythmic disorders, and among true IVF patients, those selected for catheter ablation experienced higher VF recurrence than those managed with antiarrhythmic drugs alone.
Funding Acknowledgements Type of funding sources: None. Background/Introduction Idiopathic ventricular fibrillation (IVF) is responsible for 5-7% of sudden cardiac arrests in the absence of substrate for ventricular arrhythmia, structural diseases, or primary arrhythmic syndromes. The characteristics, management, and prognosis of these patients are unclear. Purpose To investigate the clinical features, management, and prognosis of IVF in our hospital healthcare system Methods Mayo Database Explorer software was used to identify IVF patients from our hospital electronic medical records between 1990 to 2022 in 5 states. The medical records were manually reviewed. Results A total of 132 patients were initially diagnosed with IVF. During the 9.2±6.8 years mean follow-up, 36 [27.3%] patients were later diagnosed with structural diseases or primary arrhythmic syndromes (dilated cardiomyopathy [41.7%], Long QT syndrome [27.8%], catecholaminergic polymorphic ventricular tachycardia [8.3%], Brugada syndrome [5.6%], mitral valve-related arrhythmia [5.6%], and short QT syndrome [2.8%]). Among the rest of the 96 patients with true IVF (mean age 38.4±15.7 years, male 59.4%, Caucasian 80.2%, hypertension 28.1%, diabetes 8.3%), 91 (94.8%) patients presented with out-of-hospital cardiac arrest and 88 (91.7%) patients had a history of syncope. Early repolarization and fragmented QRS were noted in 32 (33.3%) and 28 (29.1%) patients, respectively. Defibrillators were implanted in 92 (95.8%) patients. Genetic testing was performed in 35 (36.5%) patients, and possible associated mutations were found in 13 (37.1%) patients. An Electrophysiology study was conducted in 55 (57.3%) patients, and ventricular fibrillation was induced in 17 (30.9%) patients. The medical management with antiarrhythmic drugs was selected in 60 (62.5%) patients, and the catheter ablation ± anti-arrhythmic drugs was selected in 36 (37.5%) patients. The recurrence of ventricular fibrillation during 9.2±6.8 years of mean follow-up was significantly higher in the ablation strategy group (p=0.0003) (Figure 1). Conclusions We reported the largest cohort of IVF patients from a single healthcare system. Early repolarization and fragmented QRS were common in IVF. The possible associated mutations were found in one-third of IVF who underwent genetic testing. The ventricular fibrillation recurrences were significantly higher in the catheter ablation strategy group.
No takes yet. Share an insight, caveat, or question.
Rattanawong et al. (2023) conducted a cohort in Idiopathic ventricular fibrillation (IVF) (n=132). Catheter ablation ± antiarrhythmic drugs vs. Medical management with antiarrhythmic drugs alone was evaluated on Recurrence of ventricular fibrillation (p=0.0003).
Synapse has enriched 10 related papers. Consider them for comparative context: